IL6R and pulmonary arterial hypertension: A meta-analysis including these PAH patients and an additional 4299 individuals from two population-based cohorts revealed an overall effect estimate of 0.81±0.01 per “C” allele (OR 2.1, p<1×10−300) but no trans-acting locus associated with circulating IL-6R (figure 4a, b).